GUFIC BIOSCIENCE - (Great Potential) Market Cap.: ₹ 549.96 Current Price: ₹ 71.10 Book Value: ₹ 5.87 P/E: 48.20 Dividend Yield: 0.07% Face Value: ₹ 1.00 Promoter Holding - 69.98% ABOUT GUFIC is a 46 years old company with a strong presence in India, among the prescription pharmaceutical, Herbal and Bulk Drugs divisions. Company is also accelerating growth by concentrating its business activities on the field of Criticare and Ferticare divisions. They are the largest manufacturers of Lyophilized injections in India and have a fully automated lyophilization plant. PROS 1. Company Objective “Aiming to become agile, best-in-class global pharmaceutical company that puts the patient at the center”. Gufic is the first to launch Doxycycline I.V for tropical fever and has introduced new life saving molecule like Caspofungin, Tigecycline and Colistimethate at very economically prices. During the year 2015-16, Gufic had applied for three paten...
The big money is never made in buying or selling, it is made in waiting. Value is what you get and price is what you pay. 90% time you should choose to emphasise value, price will automatically follow. Market is a place where a Rs 10 thing can be bought for Re 1 and vice versa, u must understand the value attached to it, before paying.